logo-loader
HealthPharma & Biotech
viewAvalon GloboCare Corp

Avalon GloboCare adds Cornell cellular therapy director to its advisory board

Yen-Michael Sheng Hsu is the founding director of the Laboratory for Advanced Cellular Therapy at Weill Cornell Medicine

Stethoscope on a keyboard
Hsu also leads the Laboratory for Advanced Cellular Engineering at New York-Presbyterian Hospital

Avalon GloboCare Corp (NASDAQ:AVCO), a cellular therapeutics company, has added a director from the medical school at Cornell to its scientific and clinical advisory board.

Yen-Michael Sheng Hsu is the founding director of the Laboratory for Advanced Cellular Therapy at Weill Cornell Medicine. While there, he oversaw the creation of a cGMP cellular therapy facility, the first of its kind.

Hsu also leads the Laboratory for Advanced Cellular Engineering at New York-Presbyterian Hospital. He holds leadership positions in the Foundation for the Accreditation of Cellular Therapy and AABB, two cellular therapy organizations.

READ: Avalon GloboCare expects to be added to Russell 3000 Index

“We are pleased to welcome Dr. Hsu to our Scientific and Clinical Advisory Board,” CEO David Jin said. “He has been an invaluable asset in our exosome-based clinical programs for liquid biopsy and regenerative therapeutics. He also brings a wealth of knowledge, experience and leadership in cellular therapy, and has an impressive track record in both translational and clinical research fields.”

Avalon is a Freehold, New Jersey-based CellTech bio-developer focused on advancing cellular therapeutics utilizing exosomes, vesicles that sit outside and operate between cells.

Contact Andrew Kessel at [email protected]

Follow him on Twitter @andrew_kessel

Quick facts: Avalon GloboCare Corp

Price: 1.64 USD

NASDAQ:AVCO
Market: NASDAQ
Market Cap: $124.08 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Avalon GloboCare Corp named herein, including the promotion by the Company of Avalon GloboCare Corp in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

2 min read